Katherine W. Falenski, Ph.D.
Affiliations: | 2006 | Virginia Commonwealth University, Richmond, VA, United States |
Area:
Neuroscience Biology, PharmacologyGoogle:
"Katherine Falenski"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Robert J. DeLorenzo | grad student | 2006 | VCU | |
| (Functional redistribution of hippocampal cannabinoid CB(1) receptors in the rat pilocarpine model of acquired epilepsy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Falenski KW, Thorpe AJ, Schlosburg JE, et al. (2010) FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1775-87 |
| Falenski KW, Carter DS, Harrison AJ, et al. (2009) Temporal characterization of changes in hippocampal cannabinoid CB(1) receptor expression following pilocarpine-induced status epilepticus. Brain Research. 1262: 64-72 |
| Carter DS, Harrison AJ, Falenski KW, et al. (2008) Long-term decrease in calbindin-D28K expression in the hippocampus of epileptic rats following pilocarpine-induced status epilepticus. Epilepsy Research. 79: 213-23 |
| Falenski KW, Blair RE, Sim-Selley LJ, et al. (2007) Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy. Neuroscience. 146: 1232-44 |
| Blair RE, Deshpande LS, Sombati S, et al. (2006) Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus. The Journal of Pharmacology and Experimental Therapeutics. 317: 1072-8 |
| Wallace MJ, Blair RE, Falenski KW, et al. (2003) The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. The Journal of Pharmacology and Experimental Therapeutics. 307: 129-37 |